FdaApplication

NDA 213983

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVIIV HEALTHCARE CO
application_typeNDA
approval_date2020-06-12

Products (1)

ProductActive ingredientStrengthDosage form
TIVICAY PDDOLUTEGRAVIR SODIUMEQ 5MG BASETABLET, FOR SUSPENSION;ORAL

1 product